All Stories

  1. Effectiveness of COVID-19 Vaccine Boosters in Children Across Pandemic and Endemic Periods
  2. Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant
  3. Response to the Letter to the Editor re Maternal and perinatal risk factors of hypospadias: a case-control study
  4. Urinary angiotensin II and angiotensin-(1–7) in gestational hypertension and preeclampsia subtypes: clinical and biochemical correlations
  5. MOG Antibody Disease (MOGAD) Presenting as Acute Disseminated Encephalomyelitis (ADEM): Insights from Cerebrospinal Fluid Cytokine Profiling
  6. Effectiveness of COVID-19 Vaccines Against Hospitalization and Severe Disease in Children with Diabetes Mellitus During Pandemic and Post-Pandemic Eras
  7. Maternal and perinatal risk factors of hypospadias: a case-control study
  8. Pierson Syndrome: An Update
  9. APOL1 kidney risk variants and outcomes in children with congenital anomalies of the kidney and urinary tract
  10. Identification and Characterization of Alamandine-(1-5), a New Component of the Renin-Angiotensin System
  11. Effectiveness of oseltamivir in hospitalised obstetric patients with COVID-19: a retrospective cohort study using a Brazilian national database
  12. Response to Commentary on “Risk factors for perinatal and neonatal mortality in cases with congenital anomalies of the kidney and urinary tract: a nested cohort study”
  13. Dynamic ultrasound evaluation of morphological and functional urinary tract characteristics in newborns and young infants with myelomeningocele
  14. Prune-belly Syndrome: An Update
  15. Psycho-neuroendocrine-immune interpretation of schizophrenia pathogenesis and treatment
  16. Risk factors for perinatal and neonatal mortality in cases with congenital anomalies of the kidney and urinary tract: a nested cohort study
  17. Comparative performance of twelve machine learning models in predicting COVID-19 mortality risk in children: a population-based retrospective cohort study in Brazil
  18. Risk factors for early mortality in infants with congenital anomalies of the kidney and urinary tract: a nested cohort study
  19. The Role of Renin-Angiotensin System in Diabetic Nephropathy: An Update
  20. COVID-19 Vaccine Effectiveness and Risk Factors of Booster Failure in 480,000 Patients with Diabetes Mellitus: A Population-Based Cohort Study
  21. Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases
  22. Neuroinflammation in kidney disease and dialysis
  23. Dental anomalies in a patient with Tyrosinemia type I: first case report in the literature
  24. Oxidative Stress in Renal Health
  25. Cytokine Profiles Associated With Clinical Outcomes in Pediatric Patients With Meningitis: A Systematic Review and Meta-Analysis
  26. Efficacy, safety, and biomarker changes of B-cell activating factor- and A proliferation-inducing ligand-targeted therapies in IgA nephropathy: A systematic review and meta-analysis of randomized controlled trials
  27. Expression of immunophenotypic markers in blood mononuclear cells of patients with advanced head and neck squamous cells carcinoma
  28. Inflammatory markers in cerebrospinal fluid in pediatric Brazilian spotted fever with neurological manifestations
  29. Strength Training can Modulate Urinary Adipokine Levels in Healthy Young Males
  30. Involvement of Renin-Angiotensin system (RAS) components in mild traumatic brain injury
  31. Vaccine protection against COVID-19-related death in patients with schizophrenia: A retrospective cohort study
  32. Kidney transplantation reduces biomarkers of endothelial dysfunction
  33. Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients
  34. A case of suicide secondary to diethylene glycol intentional ingestion
  35. Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis
  36. Urinary L-FABP as an Early Biomarker for Pediatric Acute Kidney Injury Following Cardiac Surgery with Cardiopulmonary Bypass: A Systematic Review and Meta-analysis
  37. Effectiveness of oseltamivir in reducing COVID-19-related in-hospital deaths: A pharmacoepidemiological study
  38. Translation, cross-cultural adaptation and validation of the Short Screening Instrument for Psychological Problems in Enuresis for use in Brazil (SSIPPE-Br)
  39. Potential Role of Novel Cardiovascular Biomarkers in Pediatric Patients with Chronic Kidney Disease
  40. Predictive models of chronic kidney disease progression in pediatric patients
  41. Potential urinary biomarkers in preeclampsia: a narrative review
  42. Natural history of albuminuria in a large cohort of children and adolescents with sickle cell anemia from Brazil
  43. Efficacy and Safety of SGLT2 Inhibitors in Pediatric Patients and Young Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
  44. Safety and efficacy of sotagliflozin in patients with type II diabetes mellitus and chronic kidney disease: a meta-analysis of randomized controlled trials
  45. The View of Pediatric Nephrotic Syndrome as a Podocytopathy
  46. Doença renal crônica pediátrica: índices de contagem de células sanguíneas como marcadores de inflamação
  47. Pediatric chronic kidney disease: blood cell count indexes as inflammation markers
  48. Multiple odontogenic keratocysts in a patient with Lowe syndrome: a first case report and literature review
  49. Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil
  50. Bartter-like Syndrome Induced By Tacrolimus in a Renal Transplanted Boy: A Case Report
  51. The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review
  52. Acute and Chronic Effects of Strength Training on Plasma Levels of Adipokines in Man
  53. How the COVID-19 pandemic has affected children and adolescents’ sleep habits: a systematic review
  54. Nephrotic Syndrome and Renin-angiotensin System: Pathophysiological Role and Therapeutic Potential
  55. Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials
  56. Use of C-reactive protein to guide the antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
  57. Multi-population genome-wide association study implicates immune and non-immune factors in pediatric steroid-sensitive nephrotic syndrome
  58. Renal toxicity caused by diethylene glycol: an overview
  59. Redox Signaling in Chronic Kidney Disease-Associated Cachexia
  60. Maternal risk factors for congenital anomalies of the kidney and urinary tract: A case-control study
  61. Novel Biomarkers for Posterior Urethral Valve
  62. Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years
  63. Estimated glomerular filtration rate in Brazilian adults with sickle cell disease: results from the REDS-III multicenter cohort study
  64. Imaging Markers of Neurologic Damage in COVID-19: A Systematic Review
  65. The challenges of chemotherapy adjustment in obese individuals
  66. The use and role of telemedicine in maternal fetal medicine around the world: an up-to-date
  67. Inherited Fanconi syndrome
  68. Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents
  69. Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study
  70. Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials
  71. Machine Learning Algorithms to Predict Outcomes in Children and Adolescents with Covid-19: A Systematic Review
  72. Congenital Solitary Functioning Kidney: A Review
  73. Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil
  74. Immuno-oncology in head and neck squamous cell carcinoma - a narrative review
  75. Nut-enriched energy restricted diet has potential to decrease hunger in women at cardiometabolic risk: a randomized controlled trial (Brazilian Nuts Study)
  76. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy in pediatric patients: a meta-analysis
  77. Pharmacogenomic markers of glucocorticoid response in congenital adrenal hyperplasia
  78. Relationship between primary monosymptomatic enuresis and process toilet training: a case-control
  79. Costus spiralis extract restores kidney function in cisplatin-induced nephrotoxicity model: Ethnopharmacological use, chemical and toxicological investigation
  80. Modified Levels of Renin Angiotensin Related Components in the Frontal Cortex and Hippocampus were Associated with Neuroinflammation and Lower Neuroprotective Effects of NGF During Acute Hepatic Encephalopathy in Mice
  81. Clinical Outcomes of Omicron Variant (B.1.1.529) Infection in Children and Adolescents Hospitalized With COVID-19 in Brazil With Observational Data on the Efficacy of the Vaccines in Adolescents
  82. The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil
  83. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study
  84. Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date
  85. Evaluation of novel bone metabolism markers in kidney transplant recipients
  86. Relationship between toilet training process and primary nocturnal enuresis in children and adolescents – A systematic review
  87. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study
  88. Renal Toxicity Caused by Diethylene Glycol: an Overview
  89. Multi-population genome-wide association study implicates both immune and non-immune factors in the etiology of pediatric steroid sensitive nephrotic syndrome
  90. Hemostasis and oxidative stress in chronic kidney disease in children and adolescents
  91. Acute Post-Streptococcal Glomerulonephritis in Children: A Comprehensive Review
  92. Use of C-reactive protein to guide antibiotic therapy in hospitalized patients: a systematic review and meta-analysis
  93. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients
  94. Clinical Impact and Risk Factors of Mortality in Hospitalized Children and Adolescents With Hematologic Diseases and COVID-19: An Observational Retrospective Cohort Study
  95. Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil
  96. Risk factors for acute kidney injury after liver transplantation in intensive care unit: a retrospective cohort study
  97. Interactions between the intrarenal dopaminergic and the renin–angiotensin systems in the control of systemic arterial pressure
  98. Are in‐hospital COVID‐19‐related mortality and morbidity in pregnancy associated with gestational age?
  99. The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review
  100. Renin-Angiotensin System in Huntington′s Disease: Evidence from Animal Models and Human Patients
  101. The Need to Study Clinical Outcomes in Children and Adolescents With COVID-19 From Middle- and Low-Income Regions
  102. Nephrogenesis, Renal Function, and Biomarkers in Preterm Newborns
  103. Non-surgical management of vesicoureteral junction obstruction: a case report
  104. Tubular and glomerular biomarkers of renal tissue function in the urine of fetuses with posterior urethral valves
  105. Renin-angiotensin system in normal pregnancy and in preeclampsia: A comprehensive review
  106. Potential Role of Adult Hippocampal Neurogenesis in Traumatic Brain Injury
  107. Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives
  108. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants
  109. Comparison of the First and Second Waves of the Coronavirus Disease 2019 Pandemic in Children and Adolescents in a Middle-Income Country: Clinical Impact Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Gamma Lineage
  110. Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID-19: an analysis of a nationwide database
  111. Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID ‐19 in Brazil: An analysis of a nationwide database
  112. The Curcumin Supplementation with Piperine Can Influence the Acute Elevation of Exercise-Induced Cytokines: Double-Blind Crossover Study
  113. Risk factors for COVID ‐19‐related mortality in hospitalized children and adolescents with diabetes mellitus: An observational retrospective cohort study
  114. Renin angiotensin system molecules and chemokine (C-C motif) ligand 2 (CCL2) in chronic kidney disease patients
  115. Evaluation of insertion/deletion (I/D) polymorphisms of ACE gene and circulating levels of angiotensin II in congenital anomalies of the kidney and urinary tract
  116. Nephrogenic diabetes insipidus: a comprehensive overview
  117. The potential role of renin-angiotensin system in mild traumatic brain injury
  118. Global scientific production in the pre-Covid-19 Era: An analysis of 53 countries for 22 years
  119. Acute kidney injury in pediatrics: an overview focusing on pathophysiology
  120. Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review
  121. Immunoglobulin A nephropathy in paediatrics: An up‐to‐date
  122. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
  123. Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil – Authors' reply
  124. Glucocorticoid receptor Gene (NR3C1) Polymorphisms and Haplotypes in patients with congenital adrenal hyperplasia
  125. Evaluation of Urinary Tract Dilation Classification System for Prediction of Long-Term Outcomes in Isolated Antenatal Hydronephrosis: A Cohort Study
  126. Novel Biomarkers for Lupus Nephritis in the “OMICS” Era
  127. Renin-Angiotensin System in Central Nervous System Diseases and its Interaction with COVID-19
  128. Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives
  129. An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19
  130. Biomarkers of renal function in preterm neonates at 72 h and 3 weeks of life
  131. Postnatal urinary tract dilatation classification: improvement of the accuracy in predicting kidney injury
  132. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis
  133. Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
  134. Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database
  135. Editorial: The Role of the Renin-Angiotensin System in the Central Nervous System
  136. The usefulness of copeptin for the diagnosis of nephrogenic diabetes insipidus in infancy: a case report
  137. Novel Kidney Injury Biomarkers in A Large Cohort of Children with Sickle Cell Anemia
  138. Traumatic brain injury biomarkers in pediatric patients: a systematic review
  139. Lower limb strength training (LLST) modulates serum and urinary levels of renin angiotensin system molecules in healthy young males
  140. Telomere Shortening and Psychiatric Disorders: A Systematic Review
  141. Attention deficit and hyperactivity disorder and nocturnal enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis
  142. Evaluation of Insertion/deletion (I/D) Polymorphisms of ACE Gene in Congenital Anomalies of The Kidney and Urinary Tract From a Brazilian Pediatric Population
  143. Renovascular hypertension in pediatric patients: update on diagnosis and management
  144. Circulating Angiotensin-(1–7) Is Reduced in Alzheimer’s Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study
  145. Factors Associated with Primary Hypertension in Pediatric Patients: An Up-to-Date
  146. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
  147. Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux
  148. Attention Deficit and Hyperactivity Disorder and Enuresis co-occurrence in the pediatric population: a systematic review and meta-analysis
  149. COVID-19 pandemic and the answer of science: a year in review
  150. COVID-19 and Renal Diseases: An Update
  151. ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats
  152. How is COVID-19 pandemic impacting mental health of children and adolescents?
  153. COVID-19 related coagulopathy: what is known up to now
  154. Emotional, Behavioral, and Psychological Impact of the COVID-19 Pandemic
  155. Hepatorenal syndrome in children: a review
  156. Corrigendum to “Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system” [Heliyon 6 (1) (January 2020) e03208]
  157. 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
  158. Immune-Based Therapies for Traumatic Brain Injury: Insights from Pre-Clinical Studies
  159. Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma
  160. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
  161. Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
  162. Acute kidney injury biomarkers in the critically ill
  163. TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation
  164. Análise da força de preensão palmar, sensibilidade cutânea manual e uso funcional das mãos em crianças e adolescentes com doença renal crônica em hemodiálise
  165. ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors
  166. Editorial: Developmental Disorders of the Kidney and Urinary Tract: Recent Insights From Clinical and Molecular Studies
  167. Coronavirus Disease Pandemic Is a Real Challenge for Brazil
  168. Covid-19: the renin–angiotensin system imbalance hypothesis
  169. Bartter’s syndrome: clinical findings, genetic causes and therapeutic approach
  170. Biomarkers in vesicoureteral reflux: an overview
  171. Is SARS-CoV-2 Vertically Transmitted?
  172. Renin–angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis
  173. Urinary tract infection in pediatrics: an overview
  174. Prevalence and risk factors for albuminuria and glomerular hyperfiltration in a large cohort of children with sickle cell anemia
  175. The Renin Angiotensin System and Bipolar Disorder: A Systematic Review
  176. Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade
  177. Association between dyslipidemia and CCL2 in patients undergoing hemodialysis
  178. Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia
  179. Science funding crisis in Brazil and COVID-19: deleterious impact on scientific output
  180. Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system
  181. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
  182. Renin-angiotensin system and Alzheimer’s disease pathophysiology: From the potential interactions to therapeutic perspectives
  183. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence
  184. Inflammatory biomarkers in children with cerebral palsy: A systematic review
  185. Renin angiotensin system molecules and nitric oxide local interactions in the adrenal gland of Trypanosoma cruzi infected rats
  186. Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease
  187. Anti-inflammatory effects of C-peptide on kidney of type 1 diabetes mellitus animal model
  188. Urinary tract infection in pediatrics: an overview
  189. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study
  190. Cell‐Derived Microparticles and Von Willebrand Factor in Brazilian Renal Transplant Recipients
  191. A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis
  192. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients
  193. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension
  194. Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine
  195. Distal renal tubular acidosis: genetic causes and management
  196. The protective arm of the renin‐angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  197. A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract
  198. Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease
  199. Interactions between local Renin Angiotensin System and nitric oxide in the brain of Trypanosoma cruzi infected rats
  200. Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  201. Hepatic encephalopathy: Lessons from preclinical studies
  202. Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease
  203. Brazil's endangered postgraduate system
  204. The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  205. Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome
  206. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection
  207. Pediatric lupus nephritis
  208. Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts
  209. Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease
  210. Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?
  211. A clinical predictive model of renal injury in children with congenital solitary functioning kidney
  212. A clinical predictive model of chronic kidney disease in children with posterior urethral valves
  213. RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders
  214. Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors
  215. Dental Alterations in Renal Tubular Acidosis: Case Reports
  216. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease
  217. Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia
  218. Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia
  219. SAT0118 Association of renin-angiotensin system imbalance with subclinical atherosclerosis and disease activity in rheumatoid arthritis
  220. THU0080 Serum irisin and myostatin levels in patients with rheumatoid arthritis
  221. Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals
  222. Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review
  223. The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves
  224. Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis
  225. Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis
  226. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System
  227. Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence
  228. T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome
  229. Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study
  230. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
  231. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
  232. Single Nucleotide Variants in A Family of Monozygotic Twins Discordant for the Phenotype Congenital Megaureter: A Genomic Analysis
  233. Kidney–brain axis inflammatory cross-talk: from bench to bedside
  234. Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  235. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy
  236. Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules
  237. Bj-PRO-5a and Bj-PRO 10c Found at C-Type Natriuretic Peptide Precursor of Bothrops jararaca Change Renal Function of Hypertensive Rats
  238. Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study
  239. A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates
  240. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy
  241. Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
  242. Renin angiotensin system in liver diseases: Friend or foe?
  243. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients
  244. Early changes in adipokines from overweight to obesity in children and adolescents
  245. Characterization of an experimental model of progressive renal disease in rats
  246. Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease
  247. Early changes in adipokines from overweight to obesity in children and adolescents
  248. Zika virus challenges for neuropsychiatry
  249. Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome
  250. Immunoglobulin A nephropathy: a pathophysiology view
  251. Immune markers in the RASopathy neurofibromatosis type 1
  252. ACE inhibition, ACE2 and angiotensin-(1–7) axis in kidney and cardiac inflammation and fibrosis
  253. Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients
  254. Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis
  255. Frequência de sobrepeso e obesidade em crianças e adolescentes com autismo e transtorno do déficit de atenção/hiperatividade
  256. Nutritional evaluation of children with chronic cholestatic disease
  257. Nutritional evaluation of children with chronic cholestatic disease
  258. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
  259. Chemokines as Potential Markers in Pediatric Renal Diseases
  260. Uromodulin: a new biomarker of fetal renal function?
  261. Update on the approach of urinary tract infection in childhood
  262. Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis
  263. Update on the approach of urinary tract infection in childhood
  264. Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report
  265. Propriedades psicométricas da Escala de Responsividade Social-2 para Transtornos do Espectro Autista
  266. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease
  267. Dental findings in Brazilian patients with Fanconi syndrome
  268. A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome
  269. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update
  270. Anthropometric and Biochemical Profile of Children and Adolescents with Chronic Kidney Disease in a Predialysis Pediatric Interdisciplinary Program
  271. Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients
  272. Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome
  273. Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: A preliminary study
  274. Mas in the Kidney
  275. Chemokines as Potential Markers in Pediatric Renal Diseases
  276. Mas and Inflammation
  277. Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology
  278. Congenital anomalies of the kidney and urinary tract: An embryogenetic review
  279. Angiotensin type 2 receptor gene are associated with ureteropelvic junction obstruction
  280. A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract
  281. PAX2 Polymorphisms and Congenital Abnormalities of the Kidney and Urinary Tract in a Brazilian Pediatric Population: Evidence for a Role in Vesicoureteral Reflux
  282. The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders
  283. Dental Manifestations in Two Patients With Bartter’s Syndrome
  284. Progression of CKD in children
  285. Chemokines as Potential Markers in Pediatric Renal Diseases
  286. Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract
  287. Cognitive alterations in chronic kidney disease: an update
  288. Neuropsychiatric disorders and renal diseases: an update
  289. Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates
  290. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies
  291. Profile and scientific production of Brazilian National Council of Technological and Scientific Development researchers in Pediatrics
  292. Diagnostic Accuracy of Renal Pelvic Dilatation for Detecting Surgically Managed Ureteropelvic Junction Obstruction
  293. Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis
  294. Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme
  295. Beneficial Effects of the Activation of the Angiotensin-(1–7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy
  296. Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile
  297. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
  298. Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences
  299. Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging
  300. Autoimmune hepatitis in childhood: The role of genetic and immune factors
  301. Correlation between the Degree of Hydrolysis and the Peptide Profile of Whey Protein Concentrate Hydrolysates: Effect of the Enzyme Type and Reaction Time
  302. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease
  303. Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica
  304. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases
  305. Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo
  306. Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study
  307. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis
  308. Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns
  309. Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso
  310. ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis
  311. Clinical Course of 822 Children with Prenatally Detected Nephrouropathies
  312. Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria
  313. Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
  314. Current knowledge on esophageal atresia
  315. Diagnostic criteria for autoimmune hepatitis in children: A challenge for pediatric hepatologists
  316. Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies
  317. Newer Doppler echocardiography techniques in assessment of heart function in obese patients
  318. Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury
  319. Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter’s Syndrome
  320. ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation
  321. The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease
  322. Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?
  323. Inflamação na doença renal crônica: papel de citocinas
  324. Pesquisadores do Conselho Nacional de Desenvolvimento Científico e Tecnológico na área de Cardiologia
  325. Características clínicas e laboratoriais associadas à nefroangioesclerose hipertensiva confi rmada por biópsia renal
  326. Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods
  327. Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies
  328. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups
  329. Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress
  330. Bone disease and cytokines in idiopathic hypercalciuria: a review
  331. Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity
  332. Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children
  333. Primary versus secondary hypertension in children followed up at an outpatient tertiary unit
  334. Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease
  335. Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
  336. ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats
  337. Is remifentanil an option for premedication for neonatal endotracheal intubation?
  338. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis
  339. Risk Factors for Recurrent Urinary Tract Infections in a Cohort of Patients With Primary Vesicoureteral Reflux
  340. Risk Factors for Early Onset of Diabetic Nephropathy in Pediatric Type 1 Diabetes
  341. Citocinas e quimiocinas no transplante renal
  342. Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice
  343. Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria
  344. Molecular Pathophysiology of Renal Tubular Acidosis
  345. Independent risk factors for renal damage in a series of primary vesicoureteral reflux: A multivariate analysis
  346. Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis
  347. Renin-angiotensin system in the pathogenesis of liver fibrosis
  348. Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria
  349. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme
  350. The renin–angiotensin system and diabetes: An update
  351. Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program
  352. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
  353. Development of hepatorenal syndrome in bile duct ligated rats
  354. Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients
  355. Early awakening and extubation with remifentanil in ventilated premature neonates
  356. Sedação e analgesia em neonatologia
  357. Avaliação da dor em neonatologia
  358. The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
  359. The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)
  360. Morphine versus remifentanil for intubating preterm neonates
  361. Risk of hypertension in primary vesicoureteral reflux
  362. Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease
  363. Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein
  364. Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies
  365. Predictive factors of chronic kidney disease in severe vesicoureteral reflux
  366. The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
  367. Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome
  368. Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy
  369. Nonpeptide AVE 0991 Is an Angiotensin-(1-7) Receptor Mas Agonist in the Mouse Kidney
  370. New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva’s technique
  371. The renin angiotensin system in childhood hypertension: Selective increase of angiotensin-(1-7) in essential hypertension
  372. Angiotensin-(1–7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors
  373. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
  374. Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7)
  375. Spontaneous improvement of hypertension in multicystic dysplastic kidney: a case report
  376. Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
  377. VISCERAL LARVA MIGRANS AND TROPICAL PYOMYOSITIS: A CASE REPORT
  378. Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats
  379. Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats
  380. Renal actions of angiotensin-(1-7)
  381. Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
  382. Characterization of a new angiotensin antagonist selective for angiotensin-(1–7): Evidence that the actions of angiotensin-(1–7) are mediated by specific angiotensin receptors
  383. Angiotensins